1 year return (CAGR)
269.51%
Cymabay Therapeu Exchange (NASDAQ, USD)
CBAY
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
86.46%
5 year return (CAGR)
20.25%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.73B
Price/Sales
119.98
Ent value
3.66B
Price/Book
12.76
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-4.58%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 32.48 |
| Daily high | 32.48 |
| Daily low | 32.48 |
| Daily Volume | 0K |
| 1y analyst estimate | 32.50 |
| Beta | 0.32 |
| EPS (TTM) | -0.99 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CBAY | S&P500 | |
| Current price drop from All-time high | -0.03% | -0.19% |
| Highest price drop | -92.85% | -56.47% |
| Date of highest drop | 11 Feb 2016 | 9 Mar 2009 |
| Avg drop from high | -54.62% | -10.68% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 1389 days | 1805 days |
News
No items found